Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Oncology Institute (TOI) over the last 5 years, with Q3 2025 value amounting to 2.85.

  • Oncology Institute's Asset Utilization Ratio rose 3497.29% to 2.85 in Q3 2025 from the same period last year, while for Sep 2025 it was 2.85, marking a year-over-year increase of 3497.29%. This contributed to the annual value of 2.06 for FY2024, which is 4958.95% up from last year.
  • Oncology Institute's Asset Utilization Ratio amounted to 2.85 in Q3 2025, which was up 3497.29% from 2.62 recorded in Q2 2025.
  • Over the past 5 years, Oncology Institute's Asset Utilization Ratio peaked at 2.85 during Q3 2025, and registered a low of 0.33 during Q1 2021.
  • In the last 5 years, Oncology Institute's Asset Utilization Ratio had a median value of 1.26 in 2023 and averaged 1.44.
  • The largest annual percentage gain for Oncology Institute's Asset Utilization Ratio in the last 5 years was 21226.49% (2022), contrasted with its biggest fall of 110.16% (2022).
  • Oncology Institute's Asset Utilization Ratio (Quarter) stood at 0.94 in 2021, then decreased by 1.1% to 0.93 in 2022, then surged by 63.82% to 1.52 in 2023, then surged by 47.43% to 2.24 in 2024, then grew by 27.51% to 2.85 in 2025.
  • Its Asset Utilization Ratio was 2.85 in Q3 2025, compared to 2.62 in Q2 2025 and 2.39 in Q1 2025.